Oarsman Capital’s GE HealthCare GEHC Stock Holding History

Oarsman Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,547	Closed	-$121K	–	474
2024 Q4	$121K	Sell	1,547 -164	-10%	-$13.9K	0.02%	303
2024 Q3	$161K	Buy	+1,711	New	+$144K	0.03%	272

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oarsman Capital's GEHC Position: Q1 2025 in Review

Oarsman Capital sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 1,547 shares — an estimated $121K sold.

Oarsman Capital first reported a position in GEHC in Q3 2024 and held it in 2 quarters. The position peaked at $161K in Q3 2024. 1,373 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

Oarsman Capital reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 1,547 GE HealthCare shares in Q1 2025, an estimated $121K.
Oarsman Capital first reported a position in GE HealthCare in Q3 2024 and held it in 2 quarters.
Oarsman Capital's GE HealthCare position peaked at $161K in Q3 2024.
1,373 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.